Trials / Completed
CompletedNCT01456624
Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition
A Randomized, Open Label, Single Dose, Cross-over, Phase I Trial to Investigate Safety and Pharmacokinetics of DW-ES(B) and Megace® Under Fasting and Fed Conditions in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate pharmacokinetics of Daewon DW-ES(B) 625mg/5ml and Megace 800mg/20ml in healthy male volunteers under fasting and fed condition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Megace | 800mg |
| DRUG | DW-ES(B) | 625mg |
Timeline
- Start date
- 2011-09-01
- Primary completion
- 2012-06-01
- First posted
- 2011-10-21
- Last updated
- 2014-06-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01456624. Inclusion in this directory is not an endorsement.